Searched for
HAEMOPHILIA
More patients can access key drugs after GST rate cutsRecent GST rate cuts on critical medicines are set to significantly reduce costs for treatments of conditions like multiple myeloma, lung c...- ICMR's NIIH develops simple point of care test for haemophilia A, Von Willebrand DiseaseA cost-effective point-of-care test kit has been developed in India for early diagnosis of haemophilia A and Von Willebrand Disease, offeri...
- Bharat Biotech invests Rs 600 cr to expand into cell, gene therapiesAs per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...
- Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
- Govt taking steps to increase organ donation in the country, says Mansukh MandaviyaOver 15,000 organ donations are now made annually in the country as compared to 5,000 in 2013, Union Health Minister Mansukh Mandaviya said...
- Sudden bruises & wounds that won’t stop bleeding? These are signs of haemophilia, a health condition you should know aboutThose suffering from haemophilia should avoid any sort of contact sport.
- Lockdown effect: Hospitals flag fall in blood bank reservesBlood banks across the country have reported a sharp fall in voluntary and replacement donations after the 21-day nationwide lockdown was a...
- World Haemophilia Day: Replacement therapy at young age can avert disability among patientsIndia has high proportion of haemophilia-caused disability because patients are treated through on-demand therapy.
- More life-saving medicines to become cheaper by as much as 53%The National Pharmaceutical Pricing Authority (NPPA) on Friday fixed the maximum prices of 36 medicines and revised the ceiling prices of 1...
- Pharma companies air concerns over plans to cap pricesIf finalised, the regulator will be able to cap prices of several essential medicines, including those to treat poisoning, cardiovascular d...
- Duty exemption withdrawal on drugs to boost Make in India: Government"The above action of the government to withdraw exemption also contributes to the Make in India strategy," Hansraj Gangaram Ahir said.
- Government restores customs duty exemption on three drugsThe Central Board of Excise and Customs (CBEC) in a notification restored import duty exemption on three drugs -- Octreotide, Somatropin an...
- Indian drugs cheaper, says Government on withdrawing duty exemptionThe govt defended the move to end the customs duty exemption for import of 76 life saving drugs including those for treating cancer.
- Government reviewing move to withdraw customs duty exemption for drugsA notification issued last week by Central Board of Excise and Customs had announced that customs duty exemption on the import of 74 drugs ...
- No transfer for employees with Thalassemia, Haemophiliac kidsGovernment employees who have children suffering from Thalassemia and Haemophilia will be exempted from routine transfers and will not be a...
- Claiming tax benefit on serious ailments such as thalassaemia, cancer, AIDS and haemophilia as expenses made easyFinance Ministry has made it easier to claim tax benefit on expenditure with regard to serious ailments like thalassaemia, cancer, AIDS and...
- Arun Jaitley to announce Karunya Benevolent Fund's achievementJaitley will announce the achievement of the Karunya Benevolent Fund which has distributed Rs 800 crore to 1,11,111 beneficiaries, a govern...
- Finding unity finally in deceitAt first sight it seems religion could have nothing in common with science because they’re so separate in context, meaning and purpose. Rel...
- Crowning GloryWilliam, may soon be affianced to his longtime girlfriend Kate Middleton, of solid middle class stock.
- Biogen to bring its global drug portfolio to IndiaUS-based Biogen Idec plans to roll out its entire range of medicines in the fast-growing, Rs 40,000-crore Indian retail drug market over th...
Load More
